Location · Ypsilanti, MI
Clinical trials in Ypsilanti, MI
21 recruiting studies have a site in Ypsilanti, and 3 of them accept healthy volunteers.
21 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteers
BoxX-NoAF Clinical Trial
AtriCure, Inc.
- Location
- Ypsilanti, MI + 30 other US sites
- Eligibility basics
- Ages 65+
- RecruitingHealthy volunteers
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Cleerly, Inc.
- Location
- Ypsilanti, MI + 121 other US sites
- Eligibility basics
- Ages 55+
- Recruiting
Assessment of CCM in HF With Higher Ejection Fraction
Impulse Dynamics
- Location
- Ypsilanti, MI + 64 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Hoffmann-La Roche
- Location
- Ypsilanti, MI + 121 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Hoffmann-La Roche
- Location
- Ypsilanti, MI + 112 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
Pfizer
- Location
- Ypsilanti, MI + 11 other US sites
- Eligibility basics
- Ages 12+
- Recruiting
Prevail Global Study
Medtronic Vascular
- Location
- Ypsilanti, MI + 53 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
AstraZeneca
- Location
- Ypsilanti, MI + 151 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 4
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Takeda
- Location
- Ypsilanti, MI + 77 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
Generate Biomedicines
- Location
- Ypsilanti, MI + 21 other US sites
- Eligibility basics
- Ages 12–80
- Recruiting
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System
Biotronik, Inc.
- Location
- Ypsilanti, MI + 23 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Boehringer Ingelheim
- Location
- Ypsilanti, MI + 91 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Boehringer Ingelheim
- Location
- Ypsilanti, MI + 78 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
AstraZeneca
- Location
- Ypsilanti, MI + 93 other US sites
- Eligibility basics
- Ages 18–130
- RecruitingPhase 3
A 52-week Study of Remibrutinib in IgE-mediated Food Allergy
Novartis Pharmaceuticals
- Location
- Ypsilanti, MI + 17 other US sites
- Eligibility basics
- Ages 12–65
- RecruitingPhase 3
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Merck Sharp & Dohme LLC
- Location
- Ypsilanti, MI + 11 other US sites
- Eligibility basics
- Any age listed
- Recruiting
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
Biosense Webster, Inc.
- Location
- Ypsilanti, MI + 22 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 4
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Takeda
- Location
- Ypsilanti, MI + 36 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
DalCor Pharmaceuticals
- Location
- Ypsilanti, MI + 112 other US sites
- Eligibility basics
- Ages 45+
- RecruitingPhase 2
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Mirador Therapeutics, Inc.
- Location
- Ypsilanti, MI + 42 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteers
Education & Mentorship of Advanced Practice Providers to Increase Community-based Research Within the NCORP Network, COACH-APP Trial
Wake Forest University Health Sciences
- Location
- Ypsilanti, MI + 42 other US sites
- Eligibility basics
- Ages 18+